Literature DB >> 20652417

Evidence, ethics and inclusion: a broader base for NICE.

Stephen Wilmot1.   

Abstract

The National Institute for Health and Clinical Excellence (hereafter NICE) was created in 1998 to give guidance on which treatments should be provided by the British National Health Service, and to whom. So it has a crucial role as an agent of distributive justice. In this paper I argue that it is failing to adequately explain and justify its decisions in the public arena, particularly in terms of distributive justice; and that this weakens its legitimacy, to the detriment of the National Health Service as a whole. I argue that this failure arises from the fact that NICE works within the frameworks of positivist science and liberal ethics, largely to the exclusion of other perspectives. This narrowness of view prevents NICE from properly connecting with the range of moral concerns represented in the population. I argue for NICE's deliberations to become more inclusive, both in terms of epistemology, and also in terms of ethical perspectives. And I suggest a range of perspectives that could usefully be included. Finally I offer a framework of structures, philosophies and discussion process that will enable competing perspectives to be debated fairly and productively in this process.

Mesh:

Year:  2011        PMID: 20652417     DOI: 10.1007/s11019-010-9256-1

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  19 in total

Review 1.  Utilitarianism and the measurement and aggregation of quality--adjusted life years.

Authors:  P Dolan
Journal:  Health Care Anal       Date:  2001

2.  Dialogue and decision in a moral context.

Authors:  Donald Ipperciel
Journal:  Nurs Philos       Date:  2003-10       Impact factor: 1.279

3.  Pharmacopolitics and deliberative democracy.

Authors:  Michael D Rawlins
Journal:  Clin Med (Lond)       Date:  2005 Sep-Oct       Impact factor: 2.659

4.  It's not NICE to discriminate.

Authors:  John Harris
Journal:  J Med Ethics       Date:  2005-07       Impact factor: 2.903

5.  Not just for experts: the public debate about reprogenetics in Germany.

Authors:  Kathrin Braun
Journal:  Hastings Cent Rep       Date:  2005 May-Jun       Impact factor: 2.683

6.  Balancing in ethical deliberation: superior to specification and casuistry.

Authors:  Joseph P DeMarco; Paul J Ford
Journal:  J Med Philos       Date:  2006-10

7.  Representation and legitimacy in health policy formulation at a national level: perspectives from a study of health technology eligibility procedures in the United Kingdom.

Authors:  Timothy Milewa
Journal:  Health Policy       Date:  2007-10-23       Impact factor: 2.980

Review 8.  10 years of NICE: still growing and still controversial.

Authors:  Peter Littlejohns; Sarah Garner; Nick Doyle; Fergus Macbeth; David Barnett; Carole Longson
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

9.  NICE's use of cost effectiveness as an exemplar of a deliberative process.

Authors:  Anthony J Culyer
Journal:  Health Econ Policy Law       Date:  2006-07

10.  Individual good and common good: a communitarian approach to bioethics.

Authors:  Daniel Callahan
Journal:  Perspect Biol Med       Date:  2003       Impact factor: 1.416

View more
  2 in total

1.  Prioritisation in healthcare--still muddling through.

Authors:  Bert Gordijn; Henk Ten Have
Journal:  Med Health Care Philos       Date:  2011-05

2.  A philosophical critique of the UK's National Institute for Health and Care Excellence guideline 'Palliative care for adults: strong opioids for pain relief'.

Authors:  David Fearon; Sean Hughes; Sarah G Brearley
Journal:  Br J Pain       Date:  2018-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.